Alkermes Plc (ALKS)

46.10 -0.78 (-1.66%) USD  |  NASDAQ  |  Sep 04, 16:00
45.89 -0.21 (-0.46%) After-Hours: 20:00
More

Alkermes SG&A Expense (TTM) : 841.17M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 841.17M
March 31, 2026 794.42M
December 31, 2025 701.52M
September 30, 2025 661.32M
June 30, 2025 639.93M
March 31, 2025 637.19M
December 31, 2024 645.24M
September 30, 2024 668.03M
June 30, 2024 687.10M
March 31, 2024 724.24M
December 31, 2023 712.33M
September 30, 2023 695.39M
June 30, 2023 678.72M
March 31, 2023 623.84M
December 31, 2022 601.06M
September 30, 2022 608.61M
June 30, 2022 592.05M
March 31, 2022 580.86M
December 31, 2021 560.98M
September 30, 2021 546.35M
June 30, 2021 537.79M
March 31, 2021 530.62M
December 31, 2020 538.83M
September 30, 2020 547.50M
June 30, 2020 568.55M
Date Value
March 31, 2020 591.60M
December 31, 2019 599.45M
September 30, 2019 586.22M
June 30, 2019 566.30M
March 31, 2019 549.48M
December 31, 2018 526.41M
September 30, 2018 496.08M
June 30, 2018 466.93M
March 31, 2018 437.63M
December 31, 2017 421.58M
September 30, 2017 407.83M
June 30, 2017 399.34M
March 31, 2017 386.51M
December 31, 2016 374.13M
September 30, 2016 364.46M
June 30, 2016 362.81M
March 31, 2016 338.23M
December 31, 2015 311.56M
September 30, 2015 278.89M
June 30, 2015 241.28M
March 31, 2015 220.40M
December 31, 2014 199.90M
September 30, 2014 189.27M
June 30, 2014 176.84M
March 31, 2014 159.11M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amarin Corp. Plc 76.76M
Jazz Pharmaceuticals Plc 1.679B
Prothena Corp. Plc 49.45M
ACADIA Pharmaceuticals, Inc. 620.29M
Biogen, Inc. 2.594B